1. Inicio
  2. Proyectos y Estudios
  3. ESTUDIO MULTICENTRICO, ABIERTO PARA EVALUAR EL USO CLINICO A LARGO PLAZO DEL TRATAMIENTO CON AIN457 EN PACIENTES QUE FINALICEN LOS ENSAYOS CLINICOS EN LOS QUE SE INVESTIGA AIN457 PARA EL TRATAMIENTO DE LA UVEITIS NO INFECCIOSA INTERMEDIA, POSTERIOR O PANU VEITIS. ESTUDIO SUPPORT.

ESTUDIO MULTICENTRICO, ABIERTO PARA EVALUAR EL USO CLINICO A LARGO PLAZO DEL TRATAMIENTO CON AIN457 EN PACIENTES QUE FINALICEN LOS ENSAYOS CLINICOS EN LOS QUE SE INVESTIGA AIN457 PARA EL TRATAMIENTO DE LA UVEITIS NO INFECCIOSA INTERMEDIA, POSTERIOR O PANU VEITIS. ESTUDIO SUPPORT.

Datos básicos

Código:
CAIN457C2399
Protocolo:
CAIN457C2399
EUDRACT:
2010-021239-15
NCT:
Centro:
Dotación:
Año de incio:
Año de finalización:
ENSAYO CLÍNICO

Documentos

  • No hay documentos

Participantes

Financiadores - Promotores

NOVARTIS FARMACEUTICA, S.A.

Resultados del Ensayo Clínico

AS-OCT of cyclitic membrane pre and post treatment with rtPA in the anterior chamber.

Paya, Emma Marin; (...); Llopis, Manuel Diaz

Case Reports. 10.22336/rjo.2022.37. 2022


COMPARATIVE STUDY OF ADALIMUMAB, INFLIXIMAB AND CERTOLIZUMAB IN THE TREATMENT OF CYSTOID MACULAR EDEMA DUE TO BEHCET'S DISEASE

Martin-Varillas, J. L.; (...); Blanco, R.

Meeting Abstract. 10.1136/annrheumdis-2023-eular.4397. 2023


Comparative Study of Adalimumab, Infliximab and Certolizumab Pegol in the Treatment of Cystoid Macular Edema Due to Behcet's Disease

Barroso-Garcia, Nuria; (...); Blanco, Ricardo

Article. 10.3390/jcm13237388. 2024

  • Open Access.

COMPARATIVE STUDY ON ANTI-TNF VS TOCILIZUMAB FOR TREATMENT OF REFRACTORY UVEITIC CYSTOID MACULAR EDEMA DUE TO BEHCET'S DISEASE. MULTICENTER STUDY OF 49 PATIENTS

Atienza-Mateo, B; (...); Blanco, R

Meeting Abstract. 10.1136/annrheumdis-2021-eular.307. 2021

  • Open Access.

Comparison of Treatment with Adalimumab, Infliximab and Certolizumab in Refractory Cystoid Macular Edema Due to Behcet Disease

Barroso-Garcia, Nuria; (...); Blanco, Ricardo

Meeting Abstract. 2023


HIGH DOSE INTRAVENOUS METHYLPREDNISOLONE INDUCES RAPID IMPROVEMENT OF VISUAL ACUITY IN NON-INFECTIOUS UVEITIS OF DIFFERENT IMMUNE MEDIATED INFLAMMATORY DISEASES

Vegas-Revenga, N; (...); Blanco, R

Meeting Abstract. 10.1136/annrheumdis-2021-eular.2159. 2021

  • Open Access.

High Dose Intravenous Methylprednisolone Induces Rapid Improvement of Visual Acuity in Non-Infectious Uveitis of Different Immune Mediated Inflammatory Diseases

Vegas-Revenga, Nuria; (...); Blanco, Ricardo

Meeting Abstract. 2021


Intravenous methylprednisolone induces rapid improvement in non-infectious uveitis: a multicentre study of 112 patients

Vegas-Revenga, N.; (...); Blanco, R.

Article. 2022

  • Open Access.

RAPID IMPROVEMENT IN CYSTOID MACULAR EDEMA WITH HIGH DOSE INTRAVENOUS METHYLPREDNISOLONE IN NON-INFECTIOUS UVEITIS OF DIFFERENT IMMUNE MEDIATED INFLAMMATORY DISEASES

Vegas-Revenga, N; (...); Blanco, R

Meeting Abstract. 10.1136/annrheumdis-2021-eular.3247. 2021

  • Open Access.

Rapid Improvement in Cystoid Macular Edema with High Dose Intravenous Methylprednisolone in Non-Infectious Uveitis of Different Immune Mediated Inflammatory Diseases

Vegas-Revenga, Nuria; (...); Blanco, Ricardo

Meeting Abstract. 2021


Campos de estudio

Compartir